Understanding and targeting a specific type of bone cancer in children and adolescents
Dissecting and Targeting RB1-Mutant Osteosarcoma
This study is looking at how a common bone cancer called osteosarcoma develops in kids and teens, especially those with a specific gene change, to find better ways to treat it and help improve survival rates.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11013830 on NIH RePORTER |
What this research studies
This research focuses on osteosarcoma, a common bone cancer affecting children and adolescents, particularly those with mutations in the RB1 gene. The study aims to uncover the molecular mechanisms behind this cancer's development and progression, using patient-derived induced pluripotent stem cells (iPSCs) to model the disease. By investigating the roles of specific genes like RB1 and p53, the research seeks to identify new therapeutic targets and improve treatment strategies for patients with osteosarcoma. The ultimate goal is to enhance survival rates and treatment outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adolescents diagnosed with osteosarcoma, particularly those with RB1 mutations.
Not a fit: Patients with osteosarcoma who do not have RB1 mutations or those with other types of bone cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved survival rates for patients with RB1-mutant osteosarcoma.
How similar studies have performed: Previous research using patient-derived iPSCs has shown promise in modeling cancer and identifying therapeutic strategies, indicating a potential for success in this approach.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Lee, Dung-Fang — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Lee, Dung-Fang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.